Evidence map›Paper›PMID 39613363›Full record

GuidelineAtencion primaria2024

[Prevention of infectious diseases. Update on PAPPS 2024 vaccines].

Ana Pilar Javierre Miranda, Coro Sánchez Hernández, Susana Martín Martín, Pablo Aldaz Herce, José Javier Gómez Marco, Germán Schwarz Chavarri, Cristina García Iglesias, M Isabel Gutiérrez Pérez, M Luisa Morató Agustí, Grupo de Prevención de Enfermedades Infecciosas del PAPPS

Abstract readPractice GuidelineEnglish Abstract
In one paragraph

Guideline in Atencion primaria, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ana Pilar Javierre MirandaMedicina Familiar y Comunitaria, Centro de Salud Avenida de Aragón, SERMAS, Madrid, España. Electronic address: ajavierre@iies.es.
Coro Sánchez HernándezMedicina Familiar y Comunitaria, Centro de Salud Virgen Peregrina, SERGAS, Pontevedra, España.
Susana Martín MartínMedicina Familiar y Comunitaria, Centro de Salud de Balmaseda, OSI Ezkerraldea Enkarterri Cruces, OSAKIDETZA, Vizcaya, España.
Pablo Aldaz HerceMedicina Familiar y Comunitaria, Centro de Salud San Juan, SNS, Pamplona, España.
José Javier Gómez MarcoMedicina Familiar y Comunitaria, Centro de Salud Las Calesas, SERMAS, Madrid, España.
Germán Schwarz ChavarriMedicina Familiar y Comunitaria, Centro de Salud San Blas. Conselleria de Sanitat, Generalitat Valenciana, Alicante, España.
Cristina García IglesiasMedicina Familiar y Comunitaria, Centro de Salud Rondilla I, Valladolid, España.
M Isabel Gutiérrez PérezMedicina Familiar y Comunitaria, Centro de Salud Delicias I, Valladolid, España.
M Luisa Morató AgustíMedicina Familiar y Comunitaria, Consultor Senior del Grupo de Prevención en las Enfermedades Infecciosas PAPPS-semFyC, Barcelona, España.
Grupo de Prevención de Enfermedades Infecciosas del PAPPS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination throughout life is the best way to prevent infectious diseases and improve people's quality of life. As health professionals we must know the vaccine indications and guidelines as if they were any other treatment. In the updates for this year 2024, we continue to focus on the most relevant developments in terms of indications, changes in vaccination guidelines, new vaccines incorporated into the adult calendar and even anticipating the next vaccines to be incorporated in a short period of time. We continue to insist on remembering the specific indications in risk groups, whether due to chronic diseases or immunocompromise. They are very relevant groups in which to review and complete their vaccination schedule. Nor should we forget about vaccination during pregnancy and for health workers, we must protect ourselves to protect. We have extended the chapter of vaccination for travelers, due to increasing numbers in our Primary Care consultations. And we have added a few touches of the «One Health» approach, focusing on vaccination as a tool to improve population health and contribute to the reduced use of antibiotics and thereby avoid bacterial resistance. We have tried to summarize a large part of the document in the form of tables so that it is an agile and easy-to-consult instrument in our daily care work and we do not forget to review and complete, if necessary, the vaccination schedule of all our patients. Although we focus on adults, due to the novelty and relevance in terms of reducing the burden of disease in infants, we have included a section on immunoprevention against respiratory syncytial virus with monoclonal antibodies and its indications for the next 2024-2025 season.

Indexed as

VaccinationAdolescentAdultChildChild, PreschoolFemaleHumansImmunization ScheduleInfantPregnancyWhooping CoughActividades preventivasAtención primariaEnfermedades infecciosasInfectious diseasesPreventive activitiesPrimary careVaccination of the adultVacunación del adulto

Identifiers

PMID39613363
PMCPMC11705618

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.